Quick Context: Dr Shimizu speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about A new generation high-throughput screening assay was developed using optogenetic methods.
1401b Fac Phase 1 -
Dr Shimizu speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about A new generation high-throughput screening assay was developed using optogenetic methods. All recording and editing completed by SMS Robotics/Engineering students.
Important details found
- Dr Shimizu speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about
- A new generation high-throughput screening assay was developed using optogenetic methods.
- All recording and editing completed by SMS Robotics/Engineering students.
- We'll meet with you for free or you can check out our resources below: ...
Why this topic is useful
The goal of this page is to make 1401b Fac Phase 1 easier to scan, compare, and understand before opening related resources.
Sponsored
Frequently Asked Questions
What should readers check next?
Readers should check related pages, official references, or updated sources when details matter.
Why are related topics included?
Related topics help readers compare nearby references and understand the broader subject.
What is this page about?
This page summarizes 1401b Fac Phase 1 and connects it with related entries, references, and supporting context.
Image References
Sponsored